Maravai LifeSciences(MRVI) - 2024 Q4 - Annual Results

Earnings Release Delay - Maravai LifeSciences Holdings, Inc. announced a delay in its earnings release and call originally scheduled for February 25, 2025, due to the need for additional time to complete its financial close process[5]. - The company intends to file a Form 12b-25 for late filing with the SEC on or before March 4, 2025, and plans to submit its annual report on Form 10-K for the fiscal year ended December 31, 2024, by March 18, 2025[5]. Preliminary Revenue Results - Preliminary revenue results for the year ended December 31, 2024, were included in the February 2025 Press Release, although specific figures were not disclosed in the provided content[6].